Page last updated: 2024-10-15
diaminoglyoxime
Description
diaminoglyoxime: a ballistic modifier in RDX incorporated double base propellant formulations; DAG does not have adverse effect on vulnerability and chemical stability of the propellant formulation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 135449698 |
MeSH ID | M0495018 |
Synonyms (10)
Synonym |
2580-79-2 |
diaminoglyoxime |
FT-0624615 |
AKOS030659819 |
BCP30485 |
oxalamide oxime;diaminoglyoxime; oxamide dioxime; n,n-dihydroxyoxalamidine; 2,6-dibromo-4-tolylhydrazine hydrochloride; 1,2-diamino-1,2-ethanedione dioxime |
ethanediimidamide, n,n''-dihydroxy- |
DTXSID20878687 |
cid 135449698 |
mfcd00463937 |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |